Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00327054|
Recruitment Status : Completed
First Posted : May 17, 2006
Last Update Posted : July 1, 2015
This is a pilot study.
The aim of the investigators' study is to evaluate the effectiveness of nigella sativa seed in the treatment of dyslipidemia.
Dyslipidemia is a common risk factor for cardiovascular disease, the leading cause for morbidity and mortality among patients.
Nigella sativa is an easily available and acceptable remedy to treat dyslipidemia and at a low cost.
It is expected that by scientifically determining the effectiveness of this intervention it will lead to its widespread use.
This will provide a low cost alternative to treat dyslipidemia.
|Condition or disease||Intervention/treatment||Phase|
|Hypercholesterolemia Hypertension Diabetes Mellitus Metabolic Syndrome X||Drug: Nigella sativa seed||Phase 1 Phase 2|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia: A Randomized Controlled Trial|
|Study Start Date :||February 2006|
|Study Completion Date :||March 2007|
|Experimental: Nigella sativa seed||Drug: Nigella sativa seed|
|No Intervention: Control|
- The primary end point for the trial is serum low-density lipoprotein (LDL) cholesterol concentration measured at six weeks after intervention. [ Time Frame: six weeks ]
- Serum total cholesterol concentrations measured at six weeks after intervention [ Time Frame: six weeks ]
- Serum concentrations of high-density lipoprotein (HDL) cholesterol measured at six weeks after intervention [ Time Frame: six weeks ]
- Serum triglyceride concentrations measured at six weeks after intervention [ Time Frame: six weeks ]
- Serum blood sugar concentrations measured at six weeks after intervention [ Time Frame: six weeks ]
- Blood pressure measured at six weeks after intervention [ Time Frame: six weeks ]
- Changes in serum creatinine after six weeks intervention [ Time Frame: six weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00327054
|Aga Khan University|
|Karachi, Sindh, Pakistan, 74800|
|Principal Investigator:||Waris - Qidwai||Aga Khan University, Karachi|